Monday, March 4, 2024 – 1pm – Auditoire Maisin  Khoï NGUYEN - LDRI/MNUT - Dysosmobacter welbionis in health and diseases: novel insights from bioinformatic approaches Caroline MATHIEU - LDRI/CMFA - Towards the generation of fundamental knowledge of hTDO self-association : a Systematic Study Info: mireille.alhouayek@uclouvain.be

Thursday, February 29, 2024 – 5pm – Auditoire Maisin Steven DE SOIR - Translational Research from Experimental and Clinical Pharmacology to Treatment Optimization (TFAR)/ Cellular and Molecular Pharmacology (FACM) Exploring Phage-Antibiotic Synergies for the Treatment of Biofilm-related Infectious Diseases Promotors: Francoise Van Bambeke and Jean-Paul Pirnay Related publications:

Monday, February 26, 2024 – 1pm – Auditoire Maisin  THE GUT MICROBIOTA ROLE IN SARS-CoV-2 INFECTION Dr. Patricia Brito RODRIGUES, PhD, Post-doctoral researcher - LDRI MNUT Related publications : RODRIGUES, Patrícia Brito et al. Impact of Microbiota Depletion by Antibiotics on SARS-CoV-2 Infection of K18-hACE 2 Mice. Cells, v. 11, n. 16, p.

Wednesday, February 21, 2024 – 4:30pm – Auditoire Maisin Emilia HOSTE – Integrated PharmacoMetrics, PharmacoGenomics and PharmacoKinetics - PMGK Etude du transport cellulaire de l'atorvastatine : d'une approche fondamentale à une approche translationnelle Promotor: Prof. Laure Elens – Copromotor: Prof.

Monday, February 19, 2024 – 1pm – Auditoire Maisin  Manon AUTUORI - LDRI/MNUT - Breath volatolome as a new tool to study gut microbiome – nutrition – host interactions Matthieu DELTOMBE - IoNS and LDRI/BPBL - The role of microRNAs associated with extracellular vesicles in the pathophysiology of multiple sclerosis Info: mireille.alhouayek@uclouvain.be

Thursday, February 8, 2024 – 5pm – Auditoire Central C Martin ROUMAIN – Bioanalysis and Pharmacology of Bioactive Lipids - BPBL Advances in bioactive sterol research: Metabolism and quantification of oxysterols and bile acids Promotor: Prof. Giulio Muccioli Related references: Identification and in vivo detection of side-chain hydroxylated metabolites of 4β-hydroxycholesterol.

Monday, February 5, 2024 – 1pm – Auditoire Maisin  Fanny DETROZ - LDRI ADDB and ULiège - Development of nanomedicines to tackle cystic fibrosis lung disease Clémence FAYT - MNUT - Roles of gut microbes in inter-individual food reward dysregulations during nutritional obesity Laurie HOFLACK - BPBL and ADDB - Development and pharmacological assessment of a dual nanoc

Monday, January 29, 2024 - 1pm - Auditoire Maisin Prof. Joana AZEREDO - Laboratory of Applied Health Microbiology, Centre of Biological Engineering, Universidade do Minho, Braga, Portugal Bacteriophages are effective anti-biofilm agents but need a little help Related publications : Meneses et al. A systematic review of the use of bacteriophages for in vitro biofilm control.

Monday January 22, 2024 - 1pm - Auditoire Maisin Laudine ACKERMANS – LDRI CLIP - Improving competencies of future health care professionals for deprescribing Alice BARBÉ – LDRI - PMGK, FACM and MNUT - Impact of antibiotic treatments on tacrolimus pharmacokinetics in renal transplant patients - potential influence of gut microbiota Laurane BECKERS – IREC FATH - To understand and block the metabo

Monday January 15, 2024 - 1pm - Auditoire Maisin Manon de MONTIGNY – LDRI CLIP - Management of patients with polymedication in primary care: How pills connect people? Mélina CARBONE – LDRI REMA - Cocktails of fungicides targeting cellular respiration: which benefits to counteract resistance to cryptogamic diseases for which risks for human cells exposed? Antoine GLORIEUX – LDRI FACM - Innovativ